secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2022-10-07T23:59:59+00:00
Accession:  0001193125-22-259009
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin cuts ~120 jobs, expects $50M annual savings to reinvest
----------------------------------------------------------------

- Workforce reduction of ~120 employees; pre-tax charges of $20-25M in Q3/Q4 2022.
- Expected annualized cost savings ~$50M; savings to be reinvested in operations to boost profitability.
- Majority of reductions announced Oct 6, 2022; substantially complete by Dec 31, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312522259009/0001193125-22-259009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312522259009/d383407d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-259009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer